Supplementary Figures 1 and 2 and Supplementary Table 1 from Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer ModelsPia M. Challita-Eid,Daulet Satpayev, Peng Yang, Zili An,Karen Morrison,Yuriy Shostak,Arthur Raitano,Rossana Nadell,Wendy Liu,Dawn Ratay Lortie,Linnette Capo, Alla Verlinsky,Monica Leavitt,Faisal Malik,Hector Aviña,Claudia I. Guevara,Nick Dinh,Sher Karki,Banmeet S. Anand,Daniel S. Pereira,Ingrid B.J. Joseph,Fernando Doñate,Kendall Morrison,David R. Stovercrossref（2023）引用 0|浏览8暂无评分关键词LectinsAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
